Tag: molecules-used

Swiss pharmaceutical manufacturer Lonza Group AG is in advanced talks to acquire Capsugel, a U.S. maker of capsule products and other drug delivery systems, for more than $5 billion, according to people familiar with the matter. The deal would come as Lonza seeks to boost its life sciences capabilities and produce a wider range of…